Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Cardiol Young ; 30(11): 1750-1752, 2020 Nov.
Article in English | MEDLINE | ID: mdl-32880253

ABSTRACT

Symptomatic presentation of ductal arteriosus aneurysm is usually a consequence of associated complications, including thromboembolism, infection, and compression of adjacent structures. In this case report, we present a thrombosed ductal aneurysm that developed antenatally with further postnatal progression of the thrombus and complete occlusion of the left pulmonary artery. Urgent surgical thrombectomy was successful and the post-operative course was uneventful.


Subject(s)
Aneurysm , Ductus Arteriosus, Patent , Ductus Arteriosus , Thrombosis , Aneurysm/diagnostic imaging , Aneurysm/surgery , Ductus Arteriosus/diagnostic imaging , Ductus Arteriosus/surgery , Female , Humans , Pregnancy , Pulmonary Artery
2.
Mol Genet Genomic Med ; 8(7): e1253, 2020 07.
Article in English | MEDLINE | ID: mdl-32396283

ABSTRACT

BACKGROUND: Noonan syndrome is an autosomal dominant disorder secondary to RASopathies, which are caused by germ-line mutations in genes encoding components of the RAS mitogen-activated protein kinase pathway. RIT1 (OMIM *609591) was recently reported as a disease gene for Noonan syndrome. METHODS AND RESULTS: We present a patient with RIT1-associated Noonan syndrome, who in addition to the congenital heart defect, had monocytosis, myeloproliferative disorder, and accelerated idioventricular rhythm that was associated with severe hemodynamic instability. Noonan syndrome was suspected given the severe pulmonary stenosis, persistent monocytosis, and "left-shifted" complete blood counts without any evidence of an infectious process. Genetic testing revealed that the patient had a heterozygous c.221 C>G (pAla74Gly) mutation in the RIT1. CONCLUSION: We report a case of neonatal Noonan syndrome associated with RIT1 mutation. The clinical suspicion for Noonan syndrome was based only on the congenital heart defect, persistent monocytosis, and myeloproliferative process as the child lacked all other hallmarks characteristics of Noonan syndrome. However, the patient had an unusually malignant ventricular dysrhythmia that lead to his demise. The case highlights the fact that despite its heterogeneous presentation, RIT1-associated Noonan syndrome can be extremely severe with poor outcome.


Subject(s)
Myeloproliferative Disorders/genetics , Noonan Syndrome/genetics , Phenotype , Tachycardia, Ventricular/genetics , ras Proteins/genetics , Heterozygote , Humans , Infant , Male , Mutation , Myeloproliferative Disorders/pathology , Noonan Syndrome/pathology , Tachycardia, Ventricular/pathology
3.
JACC Case Rep ; 2(2): 319-323, 2020 Feb.
Article in English | MEDLINE | ID: mdl-34317233

ABSTRACT

This paper reports a unique case of anomalous origin of the left coronary artery from the right pulmonary artery associated with scimitar syndrome. The presence of pulmonary hypertension may have contributed to maintain coronary perfusion, which likely prevented early significant coronary steal. This study reports the clinical course, diagnosis challenges, and management strategy. (Level of Difficulty: Intermediate.).

4.
Pediatr Cardiol ; 38(7): 1515-1518, 2017 Oct.
Article in English | MEDLINE | ID: mdl-28508920

ABSTRACT

Long-term prostaglandin use is commonly associated with side effects such as cortical proliferation of the bones, hypertrophic pyloric stenosis, and soft tissue swelling of the extremities. We report a neonate with critical coarctation of the aorta, who developed second and third degree atrioventricular blocks associated with prolonged prostaglandin E1 (PGE1) infusion. Interestingly, these conduction blocks only occurred at low PGE1 dose. The rhythm disturbances resolved promptly with the discontinuation of PGE1 following surgical repair.


Subject(s)
Alprostadil/adverse effects , Heart Block/chemically induced , Alprostadil/administration & dosage , Aortic Coarctation/drug therapy , Female , Heart Block/diagnosis , Humans , Infant, Newborn , Infusions, Intravenous , Telemetry/methods
5.
Pediatr Cardiol ; 38(6): 1305-1308, 2017 Aug.
Article in English | MEDLINE | ID: mdl-28512719

ABSTRACT

Congenital complete atrioventricular block (CCAVB) is a rare condition with an incidence of 1 of 20,000 live births. Hypoplastic left heart syndrome (HLHS) occurs more frequently than CCAVB and occurs in 1 of 5000 live births. HLHS in association with CCAVB is exceedingly rare. In this report, we describe a rare case of HLHS and CCAVB diagnosed in utero. Postnatal diagnosis, management and outcome are presented as well as review of the medical literature.


Subject(s)
Heart Block/congenital , Hypoplastic Left Heart Syndrome/diagnostic imaging , Adult , Cardiovascular Surgical Procedures , Female , Heart Block/complications , Heart Block/diagnostic imaging , Heart Block/surgery , Heart Transplantation , Humans , Hypoplastic Left Heart Syndrome/complications , Hypoplastic Left Heart Syndrome/surgery , Palliative Care , Ultrasonography, Prenatal
6.
Congenit Heart Dis ; 12(2): 188-195, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27862979

ABSTRACT

IMPORTANCE: There are no well-established noninvasive biomarkers for identifying patients at risk for poor outcome after surgery for congenital heart disease. Few studies have assessed prognostic accuracy of cerebral tissue oxygenation index (cTOI) measured by near infrared spectroscopy (NIRS). OBJECTIVE: To assess the utility of noninvasive NIRS monitoring as a predictor of outcomes after neonatal cardiac surgery through measurement of cTOI. To examine the utility of noninvasive NIRS monitoring in combination with lactate concentration and inotropic score in prediction of outcomes after neonatal cardiac surgery. DESIGN: Prospective longitudinal cohort study. SETTING: Operating room and cardiac intensive care unit, Children's National Heart Institute. PARTICIPANTS: Seventy-five patients with complex congenital heart disease undergoing surgical repair within first month of life. EXPOSURE: Cerebral TOI, blood lactate, and inotropic scores were measured preoperative, intraoperative and up to 24 hours postoperative. MAIN OUTCOME MEASURES: Postoperative mortality and neurodevelopmental outcome assessed by the Bayley Scales of Infant Development (BSID II). Mental and motor scores were obtained at 6, 15, and 21 months. Good outcome was defined as survival and BSID mental and motor scores ≥70 points. Poor outcome was defined as death or BSID scores <70 at most recent follow-up. RESULTS: Cohort of 75 patients prospectively followed including 40 patients with single ventricle and 35 with two ventricles. Four patients died before discharge and ten died within 21 months. Seven patients were lost to follow-up. Among survivors with follow-up (n = 54), BSID was abnormal in 25 (46%). Patients with poor outcome (n = 39) had lower mean cTOI 60 minutes off-CPB (48% vs. 58%, P = .003) and 24 hours postoperative (49% vs. 59%, P < .001), higher lactate (8.2 vs. 5.0 mmol/L, P = .005) and higher inotropic scores (10 vs. 6, P = .02) at 24 hours postoperative. ROC analysis indicated that cTOI had moderate predictive accuracy of outcome (AUC = 0.751, P < .001). Multivariable regression analysis confirmed that predictive accuracy was improved using both cTOI and lactate at 24 hours postoperative (AUC = 0.813, 95% CI: 0.705-0.921, P < .001) with optimal cutoff values <58% and >7.4 mmol/L, respectively (sensitivity = 95%). CONCLUSION: Cerebral TOI combined with lactate at 24 hours postoperative are accurate non-invasive predictive biomarkers of patient survival and neurodevelopmental outcome in neonates with CHD undergoing cardiac surgery.


Subject(s)
Brain/blood supply , Cardiac Surgical Procedures , Cerebrovascular Circulation , Heart Defects, Congenital/surgery , Lactic Acid/blood , Oxygen Consumption , Oxygen/blood , Spectroscopy, Near-Infrared , Age Factors , Area Under Curve , Biomarkers/blood , Cardiac Surgical Procedures/adverse effects , Cardiac Surgical Procedures/mortality , Child Development , District of Columbia , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/mortality , Hospital Mortality , Humans , Infant , Infant Behavior , Infant, Newborn , Logistic Models , Longitudinal Studies , Motor Activity , Multivariate Analysis , Nervous System/growth & development , Predictive Value of Tests , Prospective Studies , ROC Curve , Risk Factors , Sympathomimetics/therapeutic use , Time Factors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...